Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411736 | SCV000486721 | likely pathogenic | Classic homocystinuria | 2016-07-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002230218 | SCV001585459 | pathogenic | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2022-08-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr135Argfs*2) in the CBS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CBS are known to be pathogenic (PMID: 10338090, 12124992). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CBS-related conditions. ClinVar contains an entry for this variant (Variation ID: 371200). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000411736 | SCV004215540 | pathogenic | Classic homocystinuria | 2023-03-21 | criteria provided, single submitter | clinical testing |